Ads
related to: Moderna COVID-19 Vaccine (Spikevax)
Search results
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 2 hours agoThe firm's decision follows the U.S. Food and Drug Administration's (FDA) approval of Moderna's...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 7 days agoModerna has announced that its Phase III clinical trial of the investigational next-generation Covid...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 hours agoNeither metric lines...and sales growth of 20% to 25%. But Moderna expects the lion's share of its...
Moderna Just Gave Investors Another Reason to Buy the Stock
Motley Fool via Yahoo Finance· 4 days agoCOVID-19 vaccine and its investigational flu vaccine. mRNA-1083 knocked it out of the park in the...
Moderna (NASDAQ:MRNA) Stock Price Down 3.9% After Insider Selling
ETF DAILY NEWS· 11 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report)’s share price fell 3.9% during trading on Tuesday following insider selling activity. 1,055,980 shares changed hands during mid-day ...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 3 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
GAMMA Investing LLC Purchases 822 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 12 hours agoGAMMA Investing LLC grew its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 37.8% in the first quarter, HoldingsChannel reports. The fund owned 2,994 shares ...
Gateway - Quartz
Quartz· 2 days agoNovo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. Moderna stock surged ...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 1 day agoEverything you need to know about the art and science of drug naming in five minutes or less,...
